Tech Company Financing Transactions

Mirna Therapeutics Funding Round

On 4/30/2015, Mirna Therapeutics raised $41.8 million in Series D financing from Baxter Ventures, Celgene and Correlation Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series D
Proceeds Purpose
The funding will enable Mirna to advance its lead microRNA (miRNA) therapeutic product candidate, MRX34, into Phase 1b and Phase 2 trials in 2016. Indications for further development will be selected at the completion of Mirna's ongoing Phase 1 trial in patients with hepatocellular carcinoma, other solid tumors and hematological malignancies. The Company also plans to advance a second miRNA therapeutic candidate into clinical trials with the proceeds of this financing, as well as embark on a combination therapy development program.

Company Information

Company Status
Private & Independent
Mailing Address
2150 Woodward St. 100
Austin, TX 78744
Email Address
Mirna Therapeutics, Inc. (NASDAQ: MIRN) is a biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics and is the first to establish clinical proof-of-concept for a microRNA replacement therapy for cancer.
Mirna Therapeutics LinkedIn Company Profile
Social Media
Mirna Therapeutics Company Twitter Account
Company News
Mirna Therapeutics News
Mirna Therapeutics on Facebook
Mirna Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Paul Lammers
  Paul Lammers LinkedIn Profile  Paul Lammers Twitter Account  Paul Lammers News  Paul Lammers on Facebook
Chief Financial Officer
Alan Fuhrman
  Alan Fuhrman LinkedIn Profile  Alan Fuhrman Twitter Account  Alan Fuhrman News  Alan Fuhrman on Facebook
Chief Scientific Officer
Miguel Barbosa
  Miguel Barbosa LinkedIn Profile  Miguel Barbosa Twitter Account  Miguel Barbosa News  Miguel Barbosa on Facebook
VP - Finance
Jon Irvin
  Jon Irvin LinkedIn Profile  Jon Irvin Twitter Account  Jon Irvin News  Jon Irvin on Facebook
VP - R & D
Jay Stoudemire
  Jay Stoudemire LinkedIn Profile  Jay Stoudemire Twitter Account  Jay Stoudemire News  Jay Stoudemire on Facebook



Browse more venture capital transactions:

Prev: 4/30/2015: Sticky venture capital transaction
Next: 4/30/2015: Hedgy venture capital transaction


Share this article


News on VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary